Talecris Biotherapeutics calls $60 million of 7¾% notes due 2016

By Melissa Kory

Cleveland, May 12 - Talecris Biotherapeutics Holdings Corp. said it will redeem $60 million of its $540 million of 7¾% senior notes due 2016.

The notes will be redeemed on June 13 at 103% of par plus accrued interest to the redemption date.

Bank of New York Mellon Trust Co., NA is the redemption date.

Talecris is a Triangle Park, N.C., biotherapeutics company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.